Consumers General

Betmakers Technology Group Ltd (ASX:BET) Wins Fixed Odds U.S. Rights for 7 More Tracks

🕔7/10/2020 8:58:29 AM

The Board of BetMakers Technology Group Ltd (ASX:BET) (FRA:T07) is pleased to announce that it has secured exclusive rights to a further 7 Race Tracks in the U.S. and Canada to manage and distribute their Fixed Odds betting in the U.S. racing market.

Read Full Article

Betmakers Technology Group Ltd (ASX:BET) PointsBet first to sign with BetMakers for US Horse Racing

🕔7/9/2020 8:21:18 AM

The Board of BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to announce that the Company's wholly owned subsidiary, BetMakers DNA Pty Ltd, has signed an agreement with PointsBet New Jersey Inc. to begin Fixed Odds betting on horseracing in the New Jersey market

Read Full Article

Betmakers Technology Group Ltd (ASX:BET) Monmouth Park Racing Season Kicks Off

🕔7/3/2020 8:25:43 AM

The Board of BetMakers Technology Group Ltd (ASX:BET) (FRA:T07) is pleased to announce the start of thoroughbred racing at Monmouth Park, New Jersey, U.S., and the subsequent international distribution of the product via BetMakers' Global Racing Network ("GRN").

Read Full Article

Betmakers Technology Group Ltd (ASX:BET) Completes $35M Placement

🕔6/22/2020 10:13:17 AM

Further to the ASX announcement dated 16 June 2020, the Board of BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to announce that the Company has completed the issue and allotment of 94,594,595 fully paid ordinary shares to raise A$35 million.

Read Full Article

Betmakers Technology Group Ltd (ASX:BET) $35M Placement to Fund Growth Initiatives

🕔6/16/2020 9:16:02 AM

BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to announce that it has received firm commitments to raise A$35 million by way of a placement to sophisticated and institutional investors at an offer price of A$0.37 per new fully paid ordinary share.

Read Full Article

Cann Global Limited (ASX:CGB) Research Results Lead to Broader Auto-immune Research

🕔6/15/2020 10:11:11 AM

Cann Global Limited's (ASX:CGB) medical Cannabis research division, Medical Cannabis Research Group Pty Ltd (MCRG) entered into a research agreement to research the possibility of the use of cannabis in the treatment of autoimmune disease, specifically multiple sclerosis (MS).

Read Full Article

Cann Global Limited (ASX:CGB) Cann Global Asia Update

🕔6/15/2020 9:36:50 AM

The Board of Cann Global Limited (ASX:CGB) wishes to update our shareholders on the operations of its 55% owned subsidiary Cann Global Asia Pty Ltd, and its activities in Laos PDR.

Read Full Article